Cockcroft–Gault, CKD-EPI 2021 & KDIGO staging.
Cockcroft–Gault was derived with actual body weight. In underweight patients many clinicians use actual; in obesity, ideal or adjusted body weight reduces overestimation.
Normalised 76.6 mL/min/1.73m² · dosing weight 80.0 kg
| Cockcroft–Gault · actual (80.0 kg) | 87.3 | mL/min |
| Cockcroft–Gault · ideal (70.5 kg) | 76.9 | mL/min |
| Cockcroft–Gault · adjusted (74.3 kg) | 81.1 | mL/min |
| Cockcroft–Gault · normalised | 76.6 | /1.73m² |
| CKD-EPI 2021 (eGFR) | 84.4 | /1.73m² |
For education and planning only — not a substitute for clinical judgement or laboratory reporting. Cockcroft–Gault and CKD-EPI assume stable renal function and are unreliable in acute kidney injury, pregnancy, extremes of body size, or rapidly changing creatinine. KDIGO GFR categories (G1–G5) are defined on BSA-normalised GFR and, for G1–G2, require additional markers of kidney damage to indicate CKD. Results depend on a standardised (IDMS-traceable) creatinine assay. Always confirm drug dosing against the approved product information and local guidelines, and consult a qualified clinician.